Skip to main content

Patenting of Human Stem Cell-Based Inventions: Ethical Issues Including and Beyond the Morality Clause

  • Chapter
Translational Stem Cell Research

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

  • 1227 Accesses

Abstract

Using the goals of patent law as a starting point, controversies over patent applications are put in a wider ethical and societal context. I argue that ethical aspects are relevant in three phases: (1) before the patent application is granted, when the conditions of patentability are applied to concrete cases; (2) in the patent law, especially in interpretation and application of the so-called ”morality clause” in the European Patent Convention; (3) but also after patents have been granted. Differences between different patent systems are mentioned briefly, and the choice between more liberal and more restrictive policies is obviously not ethically neutral.

After a brief discussion of the relations between patents, economy and politics, some current criticisms of patent and patent law are discussed. Internal criticism, more or less accepting the premises of the system and trying to improve it, is distinguished from more radical, external criticism, which challenges one or several of the premises of the current patent system. This paves the way for a discussion of future relations between ethics and patent law. Some problems of definition and interpretation, again highlighting the role of values in the controversies over patents, are indicated, and the chapter concludes with a discussion of the present and future relations between EGE (European Group on Ethics) and EPO (European Patent Office).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The Agreement on Trade Related Aspects of Intellectual Property (TRIP) is administered by the World Trade Organization (WTO)

  2. 2.

    I am grateful to Nils-Eric Sahlin for helpful comments on an earlier version of this chapter

References

  1. European Parliament and Council Directive 98/44/EC on the legal protection of biotechnological inventions. Official Journal of the European Communities, 1998, L 213.

    Google Scholar 

  2. Bioethics and Patent Law. The case of Myriad genetics. WIPO Magazine, August 2006. Can be downloaded via www.wipo.int/wipo_magazine/en/2006/04/article_0003.html

  3. Schneider I. Governing the patent system in Europe: the EPO’s supranational autonomy and its need for a regulatory perspective. Sci Public Policy 2009; 36:619–29.

    Article  Google Scholar 

  4. Cyranoski D. Arsenic patent keeps drugs for rare cancer out of reach of many. Nat Med 2007; 13:1005. Epub 2007 Aug 31.

    Article  PubMed  CAS  Google Scholar 

  5. Warrell RP. Reply to “Arsenic patent keeps drugs for rare cancer out of reach of many.” Nat Med 2007; 13:1278.

    Article  PubMed  CAS  Google Scholar 

  6. Van Overwalle G. Gene patents and collaborative licensing mechanisms. Patent pools, clearing houses, open source models and liability regimes. Cambridge: Cambridge University Press, 2009.

    Book  Google Scholar 

  7. Pogge T. Freedom from poverty as a human right: who owes what to the very poor? Oxford: Oxford University Press, 2007.

    Google Scholar 

  8. Pogge T. World poverty and human rights: cosmopolitan responsibilities and reforms. 2nd expanded edition. Cambridge: Polity Press, 2008.

    Google Scholar 

  9. Bentham J. An introduction to the principles of morals and legislation. Oxford: Clarendon, 1996.

    Google Scholar 

  10. Singer P. Practical ethics. Cambridge: Cambridge University Press, 1993.

    Google Scholar 

  11. Gewirth A. Reason and morality. Chicago: University of Chicago Press, 1978.

    Google Scholar 

  12. Gewirth A. The community of rights. Chicago: University of Chicago Press, 1996.

    Google Scholar 

  13. Beyleveld D, Brownsword R. Human Dignity in Bioethics and Biolaw. Oxford and New York: Oxford University Press, 2002.

    Google Scholar 

  14. Brownsword R. Human dignity, ethical pluralism, and the regulation of modern biotechnologies. In: T. Murphy ed., New technologies and human rights. Oxford: Oxford University Press, 2009, pp. 19–84.

    Chapter  Google Scholar 

  15. Council of Europe. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. European Treaty Series – No. 164. Council of Europe, Oviedo, 4 IV, 1997.

    Google Scholar 

  16. Crisp R, Slote M (eds.). Virtue ethics. Oxford: Oxford University Press, 1997.

    Google Scholar 

  17. Chappell T (ed.). Values and virtues. Oxford: Oxford University Press, 2006.

    Google Scholar 

  18. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Differential modeling of Fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010; 6:407–11.

    Article  PubMed  CAS  Google Scholar 

  19. US Patent, Patent Number 4,736,866. Filed Jun 22, 1984, date of Patent April 12, 1988. Inventors: Leder et al.

    Google Scholar 

  20. European Patent Office. Board of appeal decision T 315/03 of July 6, 2004.

    Google Scholar 

  21. Ching LL. Canada’s supreme court rules out patents on higher life forms. ISIS, 30 Jan 03; downloadable from www.mindfully.org/GE/2003/Canada-Patents-Life30jan03.htm.

  22. European Group on Ethics EGE, Opinion on the ethical aspects of patenting inventions involving human stem cells. Opinion N° 16. Brussels, Belgium: 7 May 2002.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hermerén, G. (2011). Patenting of Human Stem Cell-Based Inventions: Ethical Issues Including and Beyond the Morality Clause. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_24

Download citation

Publish with us

Policies and ethics